THYROID HORMONE REPLACEMENT IN TOTAL THYROIDECTOMIZED PATIENTS : SYMPTOMATIC AND METABOLIC EFFECTS OF LEVOTHYROXINE MONOTHERAPY

被引:0
作者
Akdeniz, Didem Dereli [1 ]
Oztop, Mehmet Burak [2 ]
机构
[1] Izmir Econ Univ, Dept Endocrinol & Metab, Izmir, Turkey
[2] Bakircay Univ, Fac Med, Izmir, Turkey
来源
JOURNAL OF BASIC AND CLINICAL HEALTH SCIENCES | 2021年 / 5卷 / 02期
关键词
thyroid hormone replacement; L-thyroxine; euthyroidism; metabolism; TRIIODOTHYRONINE LEVELS; SERUM THYROXINE; HYPOTHYROIDISM; THERAPY;
D O I
10.30621/jbachs.916680
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Purpose: In this study, we planned to investigate the effects of L-thyroxine monotherapy on total thyroidectomized patients. The main goal of our study is to evaluate if FT4 therapy is good enough not only to maintain euthyroidism but also to provide a good quality of life and a balance in their metabolism Methods: In this study, we retrospectively evaluated 30 total thyroidectomized patients without malignancy. We compared their thyroid hormone levels, glucose metabolism, lipid metabolism, their body mass indexes, and their symptoms of thyroid problems before surgery and after one year of treatment of L-thyroxine monotherapy. Results: the pre-op and post-op thyroid hormone levels were both in the normal range but the FT4 levels were significantly higher in the 1st year results than pre-op results (1,42 +/- 0,18 vs 1,29 +/- 0,49 respectively P=0,005*) The FT3 levels also were in the normal range in pre and 1st year post-op but post-op FT3 levels were significantly lower than pre-op levels (2,25 +/- 0,27 vs 2,92 +/- 0,49 retrospectively P<0,001*). The pre-op and postop TSH levels were euthyroid and not statistically significant. The patients tended to gain weight and it seems to be because of a tendency of being insulin resistant. (HOMA-IR pre-op and post-op were 2,2 +/- 1,1 vs 2,6 +/- 1,1 P<0,01 retrospectively; pre-op and post-op weights were 69,8 +/- 9,5 vs 71,1 +/- 10,3 P=0,006* respectively). Even all of them were euthyroid the patients tended to feel hypothyroidism symptoms. Conclusion: This study demonstrates that even though they are euthyroid with FT4 treatment total thyroidectomized patients may suffer from hypothyroidism signs and symptoms and metabolic deterioration may occur in such patients. We recommend that we should aim not only to normalize s-TSH levels but also to normalize patients' metabolic parameters and improve the quality of daily life when regulating our treatments.
引用
收藏
页码:104 / 109
页数:6
相关论文
共 24 条
[1]  
BILLEWICZ WZ, 1969, Q J MED, V38, P255
[2]   What Is the Quality of Life in Patients Treated with Levothyroxine for Hypothyroidism and How Are We Measuring It? A Critical, Narrative Review [J].
Borson-Chazot, Francoise ;
Terra, Jean-Louis ;
Goichot, Bernard ;
Caron, Philippe .
JOURNAL OF CLINICAL MEDICINE, 2021, 10 (07)
[3]   Individualized Therapy for Hypothyroidism: Is T4 Enough for Everyone? [J].
Ettleson, Matthew D. ;
Bianco, Antonio C. .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (09) :E3090-E3104
[4]   Levothyroxine Monotherapy Cannot Guarantee Euthyroidism in All Athyreotic Patients [J].
Gullo, Damiano ;
Latina, Adele ;
Frasca, Francesco ;
Le Moli, Rosario ;
Pellegriti, Gabriella ;
Vigneri, Riccardo .
PLOS ONE, 2011, 6 (08)
[5]   Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism [J].
Hirata, Yu ;
Fukuoka, Hidenori ;
Iguchi, Genzo ;
Iwahashi, Yasuyuki ;
Fujita, Yasunori ;
Hari, Yusuke ;
Iga, Makiko ;
Nakajima, Shinsuke ;
Nishimoto, Yuki ;
Mukai, Miki ;
Hirota, Yushi ;
Sakaguchi, Kazuhiko ;
Ogawa, Wataru ;
Takahashi, Yutaka .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2015, 173 (02) :247-256
[6]   Thyroid function related symptoms during levothyroxine monotherapy in athyreotic patients [J].
Ito, Mitsuru ;
Miyauchi, Akira ;
Hisakado, Mako ;
Yoshioka, Waka ;
Kudo, Takumi ;
Nishihara, Eijun ;
Kihara, Minoru ;
Ito, Yasuhiro ;
Miya, Akihiro ;
Fukata, Shuji ;
Nishikawa, Mitsushige ;
Nakamura, Hirotoshi .
ENDOCRINE JOURNAL, 2019, 66 (11) :953-960
[7]   Biochemical Markers Reflecting Thyroid Function in Athyreotic Patients on Levothyroxine Monotherapy [J].
Ito, Mitsuru ;
Miyauchi, Akira ;
Hisakado, Mako ;
Yoshioka, Waka ;
Ide, Akane ;
Kudo, Takumi ;
Nishihara, Eijun ;
Kihara, Minoru ;
Ito, Yasuhiro ;
Kobayashi, Kaoru ;
Miya, Akihiro ;
Fukata, Shuji ;
Nishikawa, Mitsushige ;
Nakamura, Hirotoshi ;
Amino, Nobuyuki .
THYROID, 2017, 27 (04) :484-490
[8]  
JENNINGS PE, 1984, BMJ-BRIT MED J, V289, P1645, DOI 10.1136/bmj.289.6459.1645
[9]   Triiodothyronine levels in athyreotic individuals during levothyroxine therapy [J].
Jonklaas, Jacqueline ;
Davidson, Bruce ;
Bhagat, Supna ;
Soldin, Steven J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (07) :769-777
[10]   Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document [J].
Jonklaas, Jacqueline ;
Bianco, Antonio C. ;
Cappola, Anne R. ;
Celi, Francesco S. ;
Fliers, Eric ;
Heuer, Heike ;
McAninch, Elizabeth A. ;
Moeller, Lars C. ;
Nygaard, Birte ;
Sawka, Anna M. ;
Watt, Torquil ;
Dayan, Colin M. .
THYROID, 2021, 31 (02) :156-182